Syneos Health, Inc. Stock
Equities
SYNH
US87166B1026
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 23-06-30 |
Michael Brooks
COO | Chief Operating Officer | 50 | 21-07-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 23-09-27 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
James Dimitri
BRD | Director/Board Member | - | 23-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 8 M€ | -.--% | ||
0.77% | 2 M€ | +5.19% | ||
0.50% | 0 M€ | 0.00% | - | |
0.36% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |